Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Clasificación en acciones #24577
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Precio por acción
$1.48
Última sincronización: 2025-03-24
Capitalización bursátil
$59.05M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
GB
Comercio Achilles Therapeutics plc (ACHL)

Categoría

Historial de desdoblamientos de acciones de Achilles Therapeutics plc (ACHL)
La acción Achilles Therapeutics plc (símbolo: ACHL) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 21, 2026.
Una acción ACHL comprada antes de Aug 21, 2026 equivaldría hoy a 0 acciones ACHL.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH